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ABSTRACT We report the nucleotide sequence of a gene en-
coding a human immunoglobulin Cy,2 region. Comparison with the
previously determined C,,4 sequence reveals that these two genes
share extensive (=95%) homology in the three CH domain exons
and adjacent noncoding regions. In contrast, hinge exons have
diverged to a much greater degree, implying that natural selection
has favored the generation ofdiversity in these coding regions. We
have used the .noncoding nucleotide differences to estimate that
approximately 6-7 millionyears have elapsed since the occurrence
of the gene duplication or correction event which generated the
two identical ancestral genes. In addition we show that the two C,,
genes are arranged in human chromosomal DNA in the configu-
ration 5'-C,2-17 kilobase pairs -C,,4-3'.
IgG is the major class of antibody molecule in the serum of
mammals, representing 70-80% of the total serum immuno-
globulin in humans. It is distinguished from other classes of
antibodies by a y heavy chain constant region (C,). The Cy re-
gions of human IgG molecules are divided into four subclasses
(Cy,, Cy2, Cy3, and C,4) encoded by distinct germ-line genes(1). Protein sequence studies (2-5) have shown that the sub-
classes are highly homologous, indicating that the correspond-
ing genes derive from a common ancestral Cy gene.
Subclasses ofIgG have been observed in several other mam-
mals, although the number varies for different species (6). This
observation suggested that C, gene duplications occurred in-
dependently in various mammalian evolutionary lines after
their divergence from a common ancestor. The model assumes
that members ofa C gene family evolve independently and that
the accumulated differences in the C, genes reflect the time
elapsed since the duplication event. Molecular analyses of
mouse C, genes suggest that this simple model may not be cor-
rect (7, 8). These studies indicate that, during evolution, genetic
information has been exchanged between nonallelic mouse Cy
genes. This implies the existence of mechanisms that prevent
the C, genes from freely diverging from one another, so that
sequence homology is continually renewed within the gene
family. This postulated type of mechanism has been termed
"gene correction" (9).
We are interested in determining the structural character-
istics of human C, genes to provide insights into the evolution
of the C, gene family. We previously determined the complete
nucleotide sequence of one human C, gene, that encoding the
C,4 region (10). In this paperwe report the sequence ofa human
Cy2 gene and compare it to the C,4 sequence. In addition we
provide molecular evidence that these genes lie adjacent to one
another in human chromosomal DNA.
MATERIALS AND METHODS
Materials. The human genomic DNA library was obtained
from T. Maniatis. Sources ofnucleic acid enzymes, reagents for
DNA sequence analysis, bacteria, and the phage M13mp2were
those described by Steinmetz et aL (11).
Isolation and Subeloning of Cloned Human Chromosomal
Fragments. All cloning experiments were carried out in ac-
cordance with the recommended National Institutes of Health
guidelines for recombinant DNA research. Isolation and re-
striction mapping of DNA fragments from a human genomic
DNA library cloned in A Charon 4A.bacteriophage were done
as described (10). Either the entire Charon 4A recombinant or
the C.-containing 6.4-kilobase-pair (kb). HindIII fragment of
clone 5A was subcloned into the phage M13mp2. The DNA
was first digested with HindIII plus either Ava II or Alu I.
EcoRI-cleaved M13mp2 DNA and the fragments to be cloned
were made flush-ended by treatment with T4 DNA polymerase
and then were blunt-end ligated,(12). The ligation mixture was
used to transform Escherichia coli strain JM101, and C.,-con-
taining clones were isolated after screening of plaques (13) with
the subeloned C,4 gene from clone 24B (see Fig. 1 and ref. 10).
DNA Sequence Analysis. Individual M13 subclones were
analyzed by the dideoxy technique (14, 15) essentially as de-
scribed by Steinmetz et aL (11), except that [a-32P]dATP was
used as the labeled precursor. Alignment of the analyzed frag-
ments yielding the composite Cy DNA sequence was deter-
mined by either overlaps of Ava II and Alu I fragments or by
homology ofthe translated DNA sequence to existing sequence
data for a human 'y2 protein (3).
RESULTS
Human Cy2 and C,,4 Genes Are Linked. Human genomic
DNA clones hybridizing to a human C,3 cDNA probe were
isolated as described (10). Restriction maps for the inserts offive
of these clones indicate that the corresponding chromosomal
fragments overlap (Fig. 1). From clone blot hybridization ex-
periments with the C,3 probe, we deduce that two separate
regions on the composite stretch of human DNA contain C.Y
sequences. We have previously determined the nucleotide se-
quence of the gene on the right of Fig. 1 and found that it en-
codes a C,4 region (10). The sequence analysis of the C,4 gene
indicated that it is transcribed from left to right in Fig. 1, al-
lowing us to orient the mRNA. synonymous strand as shown.
Below we show that the gene lying 17 kb 5' to Cy4 is a C.y2 gene
and that it also is transcribed from left to right in Fig. 1. This
intergenic distance is comparable to the distances found be-
Abbreviations: CH, constant region ofheavy chain; kb, kilobase pair(s).
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tween mouse C.Y genes, which have been shown to range from
17 to 34 kb (16).
Primary Structure of a Human C,,2 Gene. The nucleotide
sequence of the Cy gene contained in clone 5A is presented in
Fig. 2. Translation ofthe coding regions indicates that this gene
is transcribed in the same direction as the Cy4 gene and that
it encodes the constant region of a y2 protein. This conclusion
is based on comparison with the complete sequence of the my-
eloma y2 protein Til (3). The predicted protein sequence agrees
with the Til sequence at all but three positions. Two of these
are differences in amide assignment: we found a glutamic acid
codon for position 20 ofthe CHI coding region and an asparagine
codon for position 84 of the CH2 exon, whereas Wang et aL (3)
found glutamine and aspartic acid, respectively, for these res-
idues. The other difference is a serine + alanine interchange
at position 60 of the CHi domain. The hinge segment, which
most clearly distinguishes the human CY subclasses, is identical
for the putative C,2 gene and protein sequences. Thus we feel
confident in classifying this gene as a C 2 gene.
Our sequence ofthe C,2 gene, whichiegins 214 nucleotides
5' to the CH1 coding region and continues 207 residues past the
termination codon, contains the same general structural fea-
tures that we previously observed for the human C,4 gene (10).
The constant region and hinge exons are separated from one
another by intervening DNA sequences (whose lengths are vir-
tually identical in the two genes), and characteristic residues
are present at the intron-exon junctions which presumably play
a role in determining the proper splicing ofthe coding segments
in the nuclear RNA precursor (17). The hexanucleotide A-A-T-
A-A-A, which has been implicated as a signal sequence for the
polyadenylylation of eukaryotic structural gene transcripts (18),
is centered 103 nucleotides 3' to the translation stop codon. As
observed for the human
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ing differences are indicated by listing the distinguishing amino
acids of the Cy4 gene. The Cy2 region contains one less amino
acid than its Cy4 counterpart; the apparent deletion is located
near the NH2 terminus of the CH2 domain [we refer to the dif-
ference as a deletion because the CH2 domains of the human
yl and y3 heavy chains contain the same number ofamino acids
as does the corresponding domain of the Cy4 region (2, 4)]. The
nucleotide sequence alignment giving maximal homology in this
region suggests that the coding difference arose from deletion
or insertion events at two sites.
Table 1 lists the nucleotide differences in the various coding
and noncoding segments of the two human genes. Two notable
features ofthe homology relationship are evident from the data.
First, the noncoding regions show nearly as much homology as
do the CH domain exons (=95%). Second, the hinge exons are
only about 70% homologous and thus are far more divergent
than any of the other coding or noncoding regions.
In studies of recently diverged genes, Perler et al. (21) de-
termined that noncoding nucleotide substitutions appear at a
rate ofapproximately 7 x 10' nucleotide substitutions per site
per year. Assuming that these substitutions are phenotypically
silent and thus not subjected to natural selection, this rate ap-
proximates the actual mutation rate and is presumed to be linear
over a relatively -short evolutionary period [about 100 million
years according to these authors (21)]. Thus we should be able
to use the data ofTable 1 to estimate the time of divergence of
the human C.y2 and C,4 genes from a common ancestral se-
quence. Using the total percentage divergence in noncoding
regions (4.6%) and the above substitution rate, we estimate that
approximately 6.6 million years have elapsed since divergence
of the human Cy2 and Cy4 genes.
C.4 gene (10) and mouse C, genes (8, DISCUSSION
e not present in the mature protein is Human C Coding Sequences. We previously observed that
terminus of the CH3 exon. the predicted protein sequence encoded in our C,4 gene differs
C d C,4 Gene Sequences. In Fig. 2 the by a single residue from the partially determined sequence of
f the human Cy2 and Cy4 genes are a human y4 protein (10). The Cy2 region encoded by the gene
rison. The substitutions leading to cod- reported here is seen to differ by three amino acid residues from
the complete sequence determined for the human y2 heavy
7kb chain Til (3). Most of the sequence of the constant region of
Cr4 another human 'y2 chain has been determined (22), and com-
t Stf f f_ f t3' parison of the three C,2sequences (two protein and one DNA)
reveals three to four. interchanges between all pairs ofcompared
sequences, most of which are due to differences in amide as-
signment. We cannot be certain that any of these differences
reflect genetic polymorphisms rather than technical artifacts.
Thus, the protein polymorphisms seen in this small sample of
ILIILLtt Cy2 and Cy4 sequences are quite limited and possibly non-
existent. This observation is not surprising, given the paucity
ofdifferent allotypes observed for human y2 and 4 chains (23).
???f t f T flIn contrast, the human yl and y3 chains exhibit a large number
of distinct genetic variants (24).
?? ?. t tOne striking feature ofthe coding sequences compared hereis the extensive divergence in the hinge exons. Fig. 2 and Table
1 reveal that the hinge exons are situated between two introns
sp of a chromosomal region containing two showing the same high degree of homology as the C exons.
lowest lines represent the human DNA in- . t
ned in Charon 4A. Positions of cleavage of Assumig that changes in intron sequences are not acted on by
rindIl (?), BamHI (t), and EcoRI (4) are in- natural selection, we expect the rate of appearance of these
aps indicate that the cloned fragments over- changes to reflect the true mutation rate. The hinge sequences,
epresent the regions encompassed by GQ cod- however, show a much greater rate of genetically fixed change
are not shown. A composite map of the than the observed presumed basal level of the introns. We be-
ned by the cloned fragments appears at the lieve that the high rate ofbase substitution in hinge exons is due
'-to-3' orientation of themRNA synonymous
es (see text). The BamHI-HindIll fragment to rapTdfixatponof the substituted nucleotides by natural se-
tgene in clone 20D is approximately 100 nu- lection. There apparently is a selective advantage to generating
orresponding fragment in clones 24B and 5D. diversity in the hinge coding region. The nature of this advan-
present allelic variation. tage is not obvious, although others have speculated about dif-
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cY2
Cr4
ABCTTTCT C6ACB6CCTGACMT CTTT SA6T6CCTAASTBCASTS6C6CCACCA6GT9CACACCCAATSCCB T"ACCCACACT96ACCCT6CCTSA=CTCGTGATAGAC
A1aSerThrLysGlyProSerVa1PheProLeuAlaProCysSerArgSerThrSerGluSerThAA6ACCOAGBGSCCTCTOCS
alThrValProSerSerAsnPheGlyThrGlnThrTyrThrCysAsnValAspHisLysProSerAsnThrLysValAspLysThrValT6ACC6T6CCCTCCA6CAACTTCOCACCCABACCTACACCT6CACuTA6ATC AA6CCACCAB6TCWAABACABTTB6T6^AB6GCCABCTCABABBA6ATBTCTBCT66uGCCAGOCTCAG
CC CA-- C A
SerLeu Lys Arg
CCCTCCT6CCT66AC6CACCCGT6T6CA6CCCA66 CCASMOCACCNCCATCTBTCTCCTCACCC6BABBCCTCTBCCC6CCCCACTCAT6CTCA6AB6ABGTCTTCTB6CTTTTTCCACCASOCT
A--A
CCA66CAGOCACAG6CT666T6CCCCTACCCCA 66CCCTTCACACACA ^6CBOTBCTTGCTCABACCTBCCAA6CCATATCC6B"GACCCT6CCCCTBACCTAABCCBACCCCAASWCAACT6TCCACT
-C--C - A C 6 T - C
GluArgLysCysCysValGluCysProProCysProCCCTCA6CTC66ACACCTTCTCTCCTCCCA6ATCC6A6TAACTCCCAATCTTCT.CTCT6CGSOCAAAT6TT6T6TC6A6T6CCCACC6T6CCCA66TAAGCCA6CCCA66CCTCGCCCTCCA6CTCAA66C666ACA
--- TCA - A T- A
Ser TyrGlyProPro Ser
6STGCCCTABABTABCCTGCATCCASBBCABGCCCCASCTSGGTSCTSACACSTCCACCTCCATCTCTTCCTCJ AlaPro ProValAlaGlyPrcSer-ValPheLeuPheProProLysProLysAspThrLeuAGCACCA CCTGTSGCASSACCGTCASTCTTCCTCTTCCCCCCAAAACCCAAGGACACCCTC
-4 ABTT- C-O 6-C
GluPheLeuGly
Gln
CAC6TTCC6T6TBBTCACCBTCCTCACCBTT6TBCACCA6"ACTSCAAQAAUAAITCATTCACCC O CC T"BACCATCTCCAAA^666G ACCAA CT6OCCCC
-A CC -T C A-
Tyr Leu SerSer Ala
GlyGInProArgGluProGlnVa1TyrThrLeuProProSerArgGluGluMetTh666TAT6A666CCACAT6BACABAACGTCBOCCCCCTCT6CCCT66"T6ACCBCTBTGCCAACCTCTBTT= TACA AC6AACCACA66T6TACACCCTTCCCCATCGAT"GATOC
Gln
rLysAsnGl nVa 1SerLeuThrCysLeuVal1Ly sGl yPheTyrProSerAsp Il1eAl aVal1Gl1uTrpGl1uSerAsnGl yG 1nProG 1uAsnAsnTyrLy sThrThrProProMetLeuAspSerAspG 1ySerPheF~heLCAA6AACCA66TCA6CCT6ACCT6CCT6BCAAGTTCT ATC6CCT66^6TTBCC u6CAACCCAT6CT66A CTCC6AC6BCTCCTTCTTCC
Val
euTyrSerLysLeuThrVal AspLysSerArgTrpGl nGl nGl yAsnVal PheSerCysSerVa lMetHi sGluAl aLeuHi sAsnHi sTyrThrGlnLysSerLeuSerLeuSerProGl yLyssTOPTCTACA6CAABCTCACC 6T61AAzACA^BOTNBCAGBTIACCTCTTCTCAT6CTCCBT"TOCAT TBCTCT6CCAACCTA S6CCTCTTCTCC6B6TTAAAM6TSC
C ^ 6 T A T
Arg Glu Leu
6CAS6CCCCCCTCCCCA66CTCTC666sTC6C6T6A^TBCTT66CA AC6TCCC CTACATACTTCCCA CCAT CAT TC-AT ATWTTCTTT
C-G C- -A
CCGTGBBTCABBCCGABTCTBABBCCTBABTGBCATBABBBABCABASTBSTC
FIG. 2. Nucleotide sequences of the human Cy2 and Y4 genes. The complete C,2 protein sequence is listed above the corresponding DNA se-
quence. Solid lines represent identity of the C.4 gene to the C,2 sequence; where differences occur, the CY4 sequence is indicated. A total of 2015
nucleotide positions are compared, including sequence gaps introduced into both genes to maintain sequence homology. Amino acid differences
encoded in the C,4 sequence are indicated by listing the C,4-specific amino acids below the corresponding codons. Note that seven nucleotides near
the 5' end of the CH2 exon are read in different translational reading frames in the two genes. "Stop" indicates the termination codon UGA. The
presumptive poly(A) addition signal sequence is marked by an asterisk.
ferences in hinge sequences leading to different effector func-
tions for the IgG subclass molecules (3, 25-28).
Other Genetic and Evolutionary Considerations. Yamawaki-
Kataoka et al. (8) performed a detailed sequence comparison of
three ofthe four mouse Cygenes, those encoding the CH regions
of yl, y2a, and y2b proteins. The homologies among these
genes are much less than the homology seen for the human C.y
genes reported here [on the order of 50-80%, depending on
the genes compared (8)]. The mouse CY genes, however, are
more similar to one another than they are to the human genes
(refs. 8 and 10, and this work). One way to explain the greater
intraspecies homologies is to postulate that the common ances-
tor of humans and mice had a single C, gene and that multiple
C, genes in the two species arose from independent gene du-
plication events occurring after speciation. Another explanation
is that the common ancestor possessed multiple C, genes and
that gene correction mechanisms have operated to maintain
sequence homology within the respective C, gene families.
According to these views, because the human CY genes are more
similar to one another than are the mouse genes, duplication
or correction events have occurred more recently in the CY
genes of humans than of mice.
Gene correction can be defined, in the context ofa multigene
family, as a genetic process whereby the sequence of all or part
Proc. Natl. Acad. Sci. USA 79 (1982)
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Table 1. Sequence differences between Cy2 and Cy4 genes
Substitutions, no.
Residues Noncoding or Difference, %
compared, synonymous Coding Silent or
Gene segment no. Gaps* coding replacement noncoding Replacement Total
Coding:
CH1 294 5 4 1.7 1.4 3.1
Hinge 36 2 9 5.6 25.0 30.6
CH2 325t 7* 9 6 2.8 1.8 4.6
CH3 321 5 5 1.6 1.6 3.2
Noncoding:
5' flanking 213 2 9 4.2 4.2
CHi-hinge intron 390 2 18 4.6 4.6
Hinge-CH2 intron 118 4 3.4 3.4
CH2-CH3 intron 97 5 5.1 5.1
3' untranslated§ 125 6 4.8 4.8
3' flanking 82 5 6.1 6.1
* These were introduced as noted in Fig. 2; the relevant residues were not compared and do not contribute to the calculation
of % difference.
t The homologous residues read in different reading frames are not compared here.
t See Fig. 2.
§ This region extends from the residue immediately 3' to the termination codon to the site of poly(A) addition. We have ten-
tatively placed this latter site 125 nucleotides 3' to the stop codon (see figure 5 of ref. 10).
of the corrected gene is replaced by the sequence of a homol-
ogous nonallelic gene (9). Two mechanisms for gene correction
among tandemly linked genes are homologous unequal cross-
over and gene conversion. Both models assume that the genetic
recombination takes place between tandem gene arrays that are
in phase but out of register, so that apposing DNA sequences
are homologous but not identical. When unequal crossover
events occur in intergenic regions, the result is expansion and
contraction of the size of the gene family. Repeated events of
this type during evolution can result in fixation of the sequence
of a single family member at the expense of the other members
(29). The result of an unequal crossover event within nonallelic
structural genes is the production of a hybrid gene, the classic
example being that of hemoglobin Lepore (30). Unlike unequal
crossovers, gene conversion events do not change the size of
the gene family. Rather, a given stretch of DNA sequence of
one gene is replaced by the sequence ofanother nonallelic gene
through a recombination event.
In light of these considerations and our determination of the
Cy2 and Cy4 gene order, it is interesting to examine the case
of a human IgG molecule that apparently resulted from a re-
combination between the Cy2 and Cy4 genes. Natvig and Kun-
kel (31) described a myeloma protein in which the CH1 and CH2
domains were characteristic of a y4 chain and the CH3 domain
resembled that of a y2 polypeptide. Fig. 3A schematically dia-
grams an unequal crossover involving Cy2 and Cy4 genes linked
in the order we have determined. Both products of the recom-
bination event contain hybrid genes; chromosome I contains
only a Lepore-like gene, whereas chromosome II contains nor-
mal Cy2 and Cy4 genes in addition to a Lepore-like gene. In
studies of sera from normal volunteers which apparently con-
tained the normal counterpart of the hybrid myeloma protein,
Natvig and Kunkel found that these individuals expressed nor-
mal IgG2 molecules, although they lacked IgG4 proteins. Chro-
mosome II of Fig. 3A conceivably could represent the configu-
ration in the DNA of these individuals, if one assumes that the
normal Cy4 gene present is not expressed. Upstream (5') to both
the normal Cy4 gene and the hybrid gene are DNA sequences
that mediate class switching. If CH switching is subclass-spe-
cific, the relevant sequences 5' to the normal Cy4 gene may be
excluded from the switching event by virtue of their being
downstream from the same sequences present near the hybrid
gene. If this explanation for the failure to express the normal
Cy4 gene is correct, it may shed some light on the mechanisms
whereby CH genes are selected for class-switch recombination.
A second explanation for the above clinical observations is
A
CY2 CY4
I
cY2 - r4
I 2
Cr2 CY4-Y2 Cr4
la ~-
B C r2 CY4
CY2 CY4-Y2
r-
CY2-Y4 CY4
._m
FIG. 3. Two models for the generation of a hybrid C,4-C2 protein.(A). Unequal crossing over. A crossover occurs between misaligned
chromosomes. The site of reciprocal exchange is indicated by the
crossed lines. The two resulting chromosomes are labeled I and II. For
simplicity we refer to the species participating in the genetic exchange
as homologous chromosomes, but sister chromatids could equally well
be involved. (B). Gene conversion. Gene conversion results in genetic
information from one gene being copied onto a second gene, thus lead-
ing to gene correction. The chromosomes resulting from the gene con-
version are labeled III and IV.
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presented schematically in Fig. 3B. Here, a gene conversion
process is proposed which involves a genetic exchange between
aligned Cy2 and Cy4 genes. Chromosome III of Fig. 3B is con-
sistent with the phenotype expressed by the volunteer individ-
uals mentioned above. The gene conversion model is the sim-
pler of the two proposals in that it does not require an ad hoc
explanation for the failure to express a normal Cy4 gene.
Several examples of apparent gene correction have been re-
ported for mammalian genes (8, 32, 33). In all of these cases,
recombination points are proposed to lie within the structural
genes rather than in intergenic regions. This conclusion follows
from the observation that the levels of homology are different
in different parts ofthe genes involved. Relatively sharp bound-
aries (representing presumed recombination break points) are
observed, on either side of which are regions of greater and
lesser homology. This pattern is evident when one examines
rodent C. sequences. For the case ofthe two most similar mouse
genes (Cy& and Cy2b), the percentage ofsilent site substitutions
in the CH1 and CH3 exons is 2-3 times greater than the cor-
responding neutral changes seen in the region between these
exons (8). Comparison ofguinea pig IgG subclass sequences also
reveals disparate levels of homology in different CH domains.
The CGY and C.2 protein sequences are >90% identical in CH1domains, whereas the homology is 64-70% in CH2 and CH3
domains (28). In contrast, the two human C. genes compared
here show a nearly constant level of homology among the dif-
ferent exons and introns (except for the hinge region, as noted
above). Thus, if a gene correction mechanism is responsible for
the extensive homology between these genes, we would pro-
pose that the recombination break points of the most recent
correction event lie outside the regions we have analyzed.
Clinical studies have uncovered a number of examples of
apparent duplications and deletions of human C. genes (34-37),
as well as several cases ofhybrid human yheavy chains (31, 38,
39). Thus, it appears that unequal crossover or gene conversion
events occur at a significant frequency among human C. genes.
These types of events can be envisioned to play a part in both
gene duplication and gene correction. It seems reasonable to
view duplication and correction as two different manifestations
of the same fundamental genetic process, one which has played
an important role in the evolution of the human C. gene family.
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